Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Article Type
Date
Availability
1-15 of 15
Keywords: interleukin-1
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Koji Akita, Kikuo Isoda, Fumie Ohtomo, Sarasa Isobe, Tomiharu Niida, Yayoi Sato-Okabayashi, Motoaki Sano, Kazunori Shimada, Yoichiro Iwakura, Tohru Minamino
Journal:
Clinical Science
Clin Sci (Lond) (2021) 135 (17): 2035–2048.
Published: 31 August 2021
... renal injury, hydralazine (Sigma–Aldrich) was administrated at the dose 250 mg/l/day in the drinking water for 14 days as described in previous report [ 13 ]. chronic kidney disease inflammation interleukin-1 renin-angiotensin system Hypertension (HT) is one of the most important cause...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2007) 112 (1): 1–25.
Published: 01 December 2006
... of the initiating event, the peripheral tissue macrophage can induce an inflammatory response through the release of the prototypical pro-inflammatory cytokines IL-1 (interleukin-1) β and TNF (tumour necrosis factor) α [ 1 ]. These cytokines act on endothelial cells to induce the expression of adhesion molecules...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2002) 102 (4): 403–409.
Published: 05 March 2002
... Society © 2002 2002 bone metabolism fatty acids interleukin-1 macrophage colony-stimulating factor osteoblasts tumour necrosis factor-. 403Clinical Science (2002) 102, 403 409 (Printed in Great Britain) Fatty acids and cytokine mRNA expression in human osteoblastic cells: a specific effect...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (1997) 92 (5): 519–525.
Published: 01 May 1997
... the effect of endotoxaemia and sepsis on brain interleukin-1 and interleukin-6 expression. 2. Male A/J mice were injected subcutaneously with lipopolysaccharide (10 mg/kg) or an equal volume of saline as control. Sepsis was induced by caecal ligation and puncture (CLP); control mice underwent sham-operation...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (1995) 88 (2): 211–217.
Published: 01 February 1995
... of interleukin 1, tumour necrosis factor and interleukin 6 were investigated in Kupffer cells derived from both young and old animals. 3. Basal production of biological response modifiers was low in cells of both young and old rats. Lipopolysaccharide stimulated production of the same types of monokines...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (1994) 87 (2): 173–178.
Published: 01 August 1994
... and butter for 4 and 8 weeks on subsequent cytokine production by peritoneal macrophages of rats. 4. Tumour necrosis factor production in response to a lipopolysaccharide stimulus and interleukin-1 and interleukin-6 production in response to a tumour necrosis factor challenge were studied. 5. All fats...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (1994) 86 (5): 619–626.
Published: 01 May 1994
... and histologically normal mucosa. 2. Addition of interleukin-1 stimulated release of greater quantities of all these inflammatory mediators, including interleukin-1 itself, from inflamed and normal mucosa. 3. Blockade of cyclo-oxygenase with indomethacin or of lipoxygenase with ICI 207968 or of phospholipase A 2...
Articles
Giulio Pioli, Guiseppina Basini, Mario Pedrazzoni, Giovanni Musetti, Vittorio Ulietti, Donatella Bresciani, Paola Villa, Alberto Bacchi, David Hughe, Graham Russell, Mario Passeri
Journal:
Clinical Science
Clin Sci (Lond) (1992) 83 (4): 503–507.
Published: 01 October 1992
...Giulio Pioli; Guiseppina Basini; Mario Pedrazzoni; Giovanni Musetti; Vittorio Ulietti; Donatella Bresciani; Paola Villa; Alberto Bacchi; David Hughe; Graham Russell; Mario Passeri 1. We studied the changes in interleukin-1 and interleukin-6 secretion by peripheral blood mononuclear cells from 12...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (1992) 82 (2): 205–209.
Published: 01 February 1992
...Rhys D. Evans; Vera Ilic; Dermot H. Williamson 1. Administration of tumour necrosis factor (cachectin) and of interleukin-1-α increased the plasma level of non-esterified fatty acids in fed rats, and in the case of interleukin-1-α the blood glycerol level was also increased, suggesting stimulation...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (1991) 81 (5): 677–683.
Published: 01 November 1991
... capacity, per cent saturation of transferrin and serum ferritin level. 4. A significant increase in interleukin-1-type activity was demonstrated immediately and 24 h after exercise ( P <0.01). 5. It is concluded that the metabolic sequelae of sustained exercise are similar, but not analogous...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (1989) 76 (5): 535–538.
Published: 01 May 1989
...-immunization. 3. The effect of rhIL-1β may be due, in part, to augmentation of the immune response to type II collagen. 4. Interleukin-1-accelerated, collagen-induced arthritis will provide a useful model for investigating the role of interleukin-1 in the regulation of arthritic diseases, and the development...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (1989) 76 (3): 261–263.
Published: 01 March 1989
... for EVA-bovine serum albumin (0.5–12.5 mg) implants. 5. These observations suggest that continuous endogenous local release of interleukin-1 or interleukin-2 in vivo is sufficient for the development of specific pathological features characterizing chronic immuno-inflammatory diseases. 1 6 1988 6...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (1988) 75 (6): 561–567.
Published: 01 December 1988
...C. I. Westacott; J. T. Whicher; C. W. Hutton; P. A. Dieppe 1. Increased spontaneous production of interleukin-1, measured as lymphocyte-activating factor activity, was seen in unstimulated monocytes from systemic sclerosis patients. 2. Inhibitory activity to interleukin-1 was seen in both normal...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (1988) 75 (3): 251–255.
Published: 01 September 1988
...J. R. Weinberg; D. J. M. Wright; A. Guz 1. The cardiovascular effects of intravenous injections of interleukin-1 (IL-1) and tumour necrosis factor (TNF) have been investigated in the conscious rabbit. They have been compared with the effects of bacterial lipopolysaccharide (LPS) because both IL-1...
Articles
J. C. W. M. Holtslag, H. J. Moshage, J. F. van Pelt, J. A. G. M. Kleuskens, F. W. J. Gribnau, S. H. Yap
Journal:
Clinical Science
Clin Sci (Lond) (1988) 74 (5): 477–483.
Published: 01 May 1988
...J. C. W. M. Holtslag; H. J. Moshage; J. F. van Pelt; J. A. G. M. Kleuskens; F. W. J. Gribnau; S. H. Yap 1. Monocytic products, especially interleukin-1 (IL-1), play an important role in the acute-phase response. Prostaglandins have been shown to act as second messengers in several physiological...